IGF2BP2 and cancer: Comparable impairment of ZIKV titers upon IGF2BP2 KD was observed in other cell lines relevant for ZIKV pathogenesis, namely human immortalized astrocytes (NHA-hTERT; Figure 2D) and cancer-derived trophoblasts (JEG-3; Figure 2E) as well as for a third wild-type ZIKV strain in Huh7.5 cells (Figure 3A), i.e., ZIKV FSS13025 (Asian lineage, isolated in Cambodia in 2010).